Results 21 to 30 of about 41,992 (300)

Periventricular remyelination failure in multiple sclerosis: a substrate for neurodegeneration.

open access: yesBrain : a journal of neurology, 2022
In multiple sclerosis, spontaneous remyelination is generally incomplete and heterogenous across patients. A high heterogeneity in remyelination may also exist across lesions within the same individual, suggesting the presence of local factors ...
Matteo Tonietto   +7 more
semanticscholar   +1 more source

Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes

open access: yesNature Neuroscience, 2020
Oligodendrocyte loss in neurological disease leaves axons vulnerable to damage and degeneration, and activity-dependent myelination may represent an endogenous mechanism to improve remyelination following injury.
Clara M. Bacmeister   +6 more
semanticscholar   +1 more source

Primary Progressive Multiple Sclerosis: New Therapeutic Approaches. [PDF]

open access: yesNeuropsychopharmacol Rep
Primary progressive MS affects 10%–15% of MS patients, causing irreversible neurological impairment. Drugs like ocrelizumab show promise, while high‐dose biotin, simvastatin, and coenzyme Q10 are under investigation. Gene therapy and stem cell treatments also show potential.
Rajabi M   +8 more
europepmc   +2 more sources

TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis

open access: yesActa Neuropathologica, 2020
Multiple sclerosis (MS) is an inflammatory, demyelinating, and neurodegenerative disease of the central nervous system (CNS) triggered by autoimmune mechanisms.
Francesca Cignarella   +19 more
semanticscholar   +1 more source

Central nervous system regeneration: the roles of glial cells in the potential molecular mechanism underlying remyelination

open access: yesInflammation and Regeneration, 2022
Glial cells play crucial roles in brain homeostasis and pathogenesis of central nervous system (CNS) injuries and diseases. However, the roles of these cells and the molecular mechanisms toward regeneration in the CNS have not been fully understood ...
Lili Quan, Akiko Uyeda, R. Muramatsu
semanticscholar   +1 more source

Delayed Demyelination and Impaired Remyelination in Aged Mice in the Cuprizone Model

open access: yesCells, 2020
To unravel the failure of remyelination in multiple sclerosis (MS) and to test promising remyelinating treatments, suitable animal models like the well-established cuprizone model are required. However, this model is only standardized in young mice. This
Stefan Gingele   +7 more
doaj   +1 more source

Versican promotes T helper 17 cytotoxic inflammation and impedes oligodendrocyte precursor cell remyelination

open access: yesNature Communications, 2022
Remyelination failure in multiple sclerosis (MS) contributes to progression of disability. The deficient repair results from neuroinflammation and deposition of inhibitors including chondroitin sulfate proteoglycans (CSPGs).
S. Ghorbani   +16 more
semanticscholar   +1 more source

Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recovery

open access: yeseLife, 2016
Demyelination in MS disrupts nerve signals and contributes to axon degeneration. While remyelination promises to restore lost function, it remains unclear whether remyelination will prevent axonal loss.
Feng Mei   +16 more
doaj   +1 more source

A higher proportion of ermin-immunopositive oligodendrocytes in areas of remyelination.

open access: yesPLoS ONE, 2021
Incomplete remyelination is frequent in multiple sclerosis (MS)-lesions, but there is no established marker for recent remyelination. We investigated the role of the oligodendrocyte/myelin protein ermin in de- and remyelination in the cuprizone (CPZ ...
Intakhar Ahmad   +3 more
doaj   +1 more source

Increased Remyelination and Proregenerative Microglia Under Siponimod Therapy in Mechanistic Models

open access: yesNeurology: Neuroimmunology & Neuroinflammation, 2022
Background and Objectives Siponimod is an oral, selective sphingosine-1-phosphate receptor-1/5 modulator approved for treatment of multiple sclerosis. Methods Mouse MRI was used to investigate remyelination in the cuprizone model.
Michael Dietrich   +26 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy